VMP 42043511000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Tizanidine 4mg tablets
BNF code 1002020T0AAAAAA
Virtual Therapeutic Moiety Tizanidine
Date identifier became valid 7 Jul 2023
Previous product identifier 330136002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Tizanidine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 373440006
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Tizagelan 4mg tablets (G.L. Pharma UK Ltd)
Tizanidine 4mg tablets (A A H Pharmaceuticals Ltd)
Tizanidine 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Tizanidine 4mg tablets (Medihealth (Northern) Ltd)
Tizanidine 4mg tablets (Niche Generics Ltd)
Tizanidine 4mg tablets (Phoenix Healthcare Distribution Ltd)
Tizanidine 4mg tablets (Sigma Pharmaceuticals Plc)
Tizanidine 4mg tablets (Sigma Pharmaceuticals Plc)
Tizanidine 4mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Tizanidine 4mg tablets 120 tablet
Tizanidine 4mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.

Feedback